Brief: Climb Bio Inc - Clym116 Phase 1 Trial Initiation Expected In Q4 2025
29/09/2025 12:10
Sept 29 (Reuters) - Climb Bio Inc CLYM.O: CLIMB BIO INC - CLYM116 PHASE 1 TRIAL INITIATION EXPECTED IN Q4 2025 Source text: ID:nGNX66L35w Further company coverage: CLYM.O ((Reuters.Briefs@thomsonreuters.com;))